Cisen Pharmaceutical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	425.62	508.91	521.34	349.96	334.15
Depreciation & Amortization	201.16	218.4	233.89	230.25	219.49
Other Amortization	0.47	6.54	1.96	0.98	3.14
Loss (Gain) From Sale of Assets	0.71	0.14	-0.59	-0.97	-0.27
Asset Writedown & Restructuring Costs	-28.83	56.66	74.27	13.06	21.34
Loss (Gain) From Sale of Investments	-123.47	-72.83	-33.74	-15.56	-66.42
Provision & Write-off of Bad Debts	-	-4.16	2.34	16.46	-5.92
Other Operating Activities	61.26	12.44	10.84	6.83	-1.68
Change in Accounts Receivable	-102.24	-20.82	-336.44	-542.34	-113.29
Change in Inventory	178.69	-115.04	-144.31	18.1	-14.81
Change in Accounts Payable	-144	4.55	118.51	197.67	-113.8
Change in Other Net Operating Assets	-9.34	-25.94	-4.92	-18.73	-9.26
Operating Cash Flow	466.37	570.85	451.24	258.35	233.6
Operating Cash Flow Growth	-18.30%	26.51%	74.67%	10.59%	-45.80%
Capital Expenditures	-64.76	-101.81	-17.71	-35.19	-51.02
Sale of Property, Plant & Equipment	3.36	0.49	0.76	0.01	0.49
Cash Acquisitions	-	-	0.42	-	-
Investment in Securities	-	16	-408.36	-274.13	289.99
Other Investing Activities	-112.41	63.57	46.77	36.23	88.02
Investing Cash Flow	-173.82	-21.75	-378.13	-273.08	327.48
Long-Term Debt Issued	15.34	53.33	54	250	138
Total Debt Issued	15.34	53.33	54	250	138
Long-Term Debt Repaid	-70.81	-137.25	-59.05	-232.43	-340.24
Total Debt Repaid	-70.81	-137.25	-59.05	-232.43	-340.24
Net Debt Issued (Repaid)	-55.46	-83.92	-5.05	17.57	-202.24
Common Dividends Paid	-182.92	-304.56	-156.13	-139.54	-120.73
Other Financing Activities	6.43	23.85	27.38	230.16	4.54
Financing Cash Flow	-231.96	-364.63	-133.8	108.19	-318.43
Foreign Exchange Rate Adjustments	-0.79	0.36	0.65	0.65	-0.22
Net Cash Flow	59.8	184.83	-60.04	94.11	242.43
Free Cash Flow	401.61	469.04	433.53	223.15	182.58
Free Cash Flow Growth	-14.38%	8.19%	94.27%	22.22%	-20.18%
Free Cash Flow Margin	11.66%	11.78%	9.71%	5.49%	4.83%
Free Cash Flow Per Share	0.89	1.03	0.96	0.49	0.40
Cash Interest Paid	-	0.45	0.6	0.44	0.38
Cash Income Tax Paid	334.19	389.98	433.03	357.12	390.99
Levered Free Cash Flow	-	499.47	443.54	283.19	137.89
Unlevered Free Cash Flow	-	503.81	447.66	285.87	141.7
Change in Working Capital	-70.55	-155.24	-359.05	-342.66	-270.23

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.